Tech Company Financing Transactions

HistoSonics Funding Round

On 6/9/2020, HistoSonics raised $40 million in Series C funding from YJ Capital, Johnson & Johnson Development Corporation and Lumira Capital .

Transaction Overview

Company Name
HistoSonics
Announced On
6/9/2020
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series C
Investors

YJ Capital (Lead Investor) (Wen Chen)

Johnson & Johnson Development Corporation

Lumira Capital (Gerry Brunk)

State of Wisconsin Investment Board

Varian Medical Systems (Gregory Sorensen)

Venture Investors (James Adox)

Proceeds Purpose
The company intends to use the funds to accelerate activities focused on its Edison� Platform, as well as launch new strategic projects.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3526 West Liberty Rd. 100
Ann Arbor, MI 48103
USA
Phone
(734) 926-4630
Website
www.histosonics.com
Email Address
[email protected]
Overview
HistoSonics Inc. is a new medical device company that is developing histotripsy, a non-invasive, image-guided therapeutic ultrasound technology.
Profile
HistoSonics LinkedIn Company Profile
Social Media
HistoSonics Company Twitter Account
Company News
HistoSonics News
Facebook
HistoSonics on Facebook
YouTube
HistoSonics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Blue
  Michael Blue LinkedIn Profile  Michael Blue Twitter Account  Michael Blue News  Michael Blue on Facebook
Chief Financial Officer
Eric Bosler
  Eric Bosler LinkedIn Profile  Eric Bosler Twitter Account  Eric Bosler News  Eric Bosler on Facebook
Vice President
Michele Bossert
  Michele Bossert LinkedIn Profile  Michele Bossert Twitter Account  Michele Bossert News  Michele Bossert on Facebook
VP - Marketing
Josh King
  Josh King LinkedIn Profile  Josh King Twitter Account  Josh King News  Josh King on Facebook
VP - Operations
Daniel Bulver
  Daniel Bulver LinkedIn Profile  Daniel Bulver Twitter Account  Daniel Bulver News  Daniel Bulver on Facebook
VP - R & D
Josh Stopek
  Josh Stopek LinkedIn Profile  Josh Stopek Twitter Account  Josh Stopek News  Josh Stopek on Facebook
VP - Regulatory Affairs
Daniel Kosednar
  Daniel Kosednar LinkedIn Profile  Daniel Kosednar Twitter Account  Daniel Kosednar News  Daniel Kosednar on Facebook
VP - Sales
Jonathon Pons
  Jonathon Pons LinkedIn Profile  Jonathon Pons Twitter Account  Jonathon Pons News  Jonathon Pons on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/9/2020: Clover Biopharmaceuticals venture capital transaction
Next: 6/9/2020: Clean Crop Technologies venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.